Press release
Global Migraine Market Research Report, Size, Share Forecast By 2022 | Top Key Players are Allergan, Abbott Laboratories, Eisai Inc., Eli Lilly and Company, Pfizer, Johnson & Johnson, Klaria, Merck
Market Overview:Migraine is a debilitating pain disorder characterized by moderate to severe recurrent headaches. According to the report that has been published by Market Research Future (MRFR), the global migraine market is anticipated to grow at a steady rate in the coming years.
Market Drivers and Restraints:
Migraine is one of the common disorders that cause tender headaches and is generally associated with other indications such as nausea, vomiting and sensitivity to light, smell and sound. The occurrence of migraine is common in females rather than males. Hence global increase in population, especially female population has resulted in increased prevalence of migraine leading to the high demand for effective treatments in the global migraine market.
The underlying mechanism of migraine is not fully known. However, increasing incidences of migraine that is triggered due to other causative disorders are fueling the growth of the global migraine market. Absence of permanent cure for migraine and growing genericization of drugs are creating multiple opportunities for pharmaceutical companies to introduce effective medication and treatment for the condition, leading to the growth of the global migraine market.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2381
Changing lifestyles, increasing stress levels and rise in prevalence of hormonal imbalance leading to migraine are inducing high demand for proper medication in the global market, which in turn is driving the global migraine market towards higher verticals. On the flip side, over-reliance on over-the-counter painkillers and easy availability of generics are likely to act as restraints on the growth of the global migraine market.
Key Players:
The leading players profiled by MRFR in the report on the global migraine market are Allergan, Impax Laboratories, Abbott Laboratories, Inc., Eisai Inc., Eli Lilly and Company, Pfizer, Inc., Johnson & Johnson, Klaria, Kowa Pharmaceuticals America, Luitpold Pharmaceuticals, Meda, Merck, OptiNose, AstraZeneca plc, and GlaxoSmithKline Plc.
Market Segmentation:
The global migraine market has been segmented on the basis of types, treatment types and drug class. Based on types, the migraine market is segmented into episodic and chronic. Based on treatment types, the migraine market is segmented into abortive and preventive. Based on drug class, the migraine market is segmented into triptans, ergots and others.
Ask Questions To The Experts @ https://www.marketresearchfuture.com/enquiry/2381
Industry Updates:
In August 2018, University of Melbourne has launched a new course named 'Mastering migraine management' which highlights the latest advances in migraine diagnosis and treatments for general practitioners. This course was built in one year by a team of neurologists and is made available on any smart device.
Regional Analysis:
Geographically, the global migraine market is segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. Increasing healthcare expenditure, rise in prevalence of migraine and availability of specialty migraine drugs are driving the migraine market in the North America region. The growth of migraine market in the Asia Pacific region is fueled by increasing investments by key players in the emerging market in the developing economies of India and China. The migraine market in the Europe region is projecting high growth potential owing to the increasing demand for effective treatment for migraine in this region.
TABLE OF CONTENTS
1 Report Prologue
2 Introduction
2.1 Research Objective
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
…Continued!
Get full report & TOC @: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=2381
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Migraine Market Research Report, Size, Share Forecast By 2022 | Top Key Players are Allergan, Abbott Laboratories, Eisai Inc., Eli Lilly and Company, Pfizer, Johnson & Johnson, Klaria, Merck here
News-ID: 1677198 • Views: …
More Releases from Market Research Future (MRFR)

Tofu Market to Reach USD 2.7 Billion by 2032 at 9.01% CAGR Driven by Rising Plan …
The global tofu market is poised for substantial growth over the next decade, projected to reach an impressive valuation of USD 2.7 billion by 2032. This expansion reflects a compound annual growth rate (CAGR) of 9.01% from 2024 to 2032, fueled by a surge in consumer demand for plant-based foods and an evolving global food culture. As more consumers seek healthier and sustainable alternatives to animal-based protein sources, tofu has…

Plant-Based Food Ingredients Market to Hit USD 40.2 Billion by 2035 at 7.96% CAG …
The global plant-based food ingredients market is witnessing remarkable growth, propelled by an increasing shift in consumer preferences toward healthier and more sustainable food options. According to recent market research by Market Research Future, the market was valued at USD 16.03 billion in 2023 and is projected to reach an impressive USD 40.2 billion by 2035. This growth trajectory is expected to continue at a compound annual growth rate (CAGR)…

Semolina Market to Reach USD 2.57 Billion by 2032 at 2.31% CAGR, Driven by Healt …
The global semolina market is poised for steady growth over the coming decade, with its valuation expected to reach USD 2.57 billion by 2032. According to the latest Market Research Future analysis, the market was valued at USD 2.12 billion in 2023 and is projected to expand from USD 2.14 billion in 2024 to USD 2.57 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.31% during the…

Ginger Extract Market to Reach USD 2.18 Billion by 2034 at 5.4% CAGR Driven by D …
The global ginger extract market is poised for substantial growth in the coming decade, with a projected valuation of USD 2.18 billion by 2034. According to the latest analysis from Market Research Future, the market was valued at USD 1.29 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. This robust growth trajectory is largely fueled by increasing…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…